DoH, M42 launch region’s largest hybrid cord blood bank

ABU DHABI: The Department of Health – Abu Dhabi (DoH) and M42 have collaborated to launch the Abu Dhabi Biobank, with its first offering being the region’s largest hybrid cord blood bank.

Reinforcing the Emirate’s position as a leading destination for life sciences, the initiative aims to shorten waiting times for treatment, increase therapeutic access for patients, improve survival rates and reduce the economic burden on governments.

Announced at the inaugural Abu Dhabi Global Healthcare Week 2024 where M42 is participating as the Foundation Partner, the Abu Dhabi Biobank is part of the emirate’s vision of building a unique global biobanking hub delivering invaluable data assets for maximal impact on people’s health.

It will be a key pillar of health transformation and aims to deliver excellence by creating a diverse, foundational, bio-asset that supports therapeutic treatments, life science research for medical innovation, novel drug discovery targets and disease prevention to deliver the highest level o
f personalised, precise, and preventative healthcare for all.

The service will be introduced across four leading healthcare entities committed to maternal and child health across Abu Dhabi. Prospective parents can avail themselves of this service at Danat Al Emarat Hospital for Women and Children, part of the M42 group, Corniche Hospital, Kanad Hospital, and hospitals as part of NMC Healthcare.

Dr. Noura Khamis Al Ghaithi, Undersecretary of DoH, said that the wealth of biological and medical data amassed by the Biobank will catalyse scientific breakthroughs, expediting drug discovery, thus contributing to the Emirate’s ability to find solutions for local and global health challenges. It will significantly impact clinical care and patient outcomes, emphasising cord-derived stem cell therapies and enabling local stem cell therapy delivery.

She added, “The Abu Dhabi Biobank’s ability to link cord blood, tissue, stem cells, and a wide range of normal and pathological human specimens with established large geno
mic, proteomics and clinical records sets the scene for transformative and cutting-edge initiatives.”

An important advancement for the nation’s health ecosystem, the cord blood bank of Abu Dhabi Biobank will enable better care outcomes, build the nation’s self-sufficiency in meeting the urgent need for cord blood stem cells, and further enhance regional capabilities in research and innovation.

Stem cells work like a ‘bio repair kit’, helping to heal, restore and replenish other cells that can be used to treat certain haematological and immune system disorders, like leukaemia, lymphoma and bone marrow diseases requiring a transplant.

With a capacity to store 100,000 cord blood samples and five million pan-human samples, the Biobank will create a rich, diverse dataset that can provide ready and better-matched hemopoietic stem cells globally. It aims to enhance community well-being through preventive measures and access to advanced, high-quality health services.

Abu Dhabi Biobank’s cord blood bank facility,
situated in M42’s Omics Centre of Excellence, is equipped with state-of-the-art automated technology and the best large-capacity biobanking infrastructure. This infrastructure will preserve samples safely and securely, thereby making them viable for research and therapeutic use for 30 years.

Ashish Koshy, Group Chief Operating Officer of M42, said, “The Abu Dhabi Biobank will foster global innovation in therapy development, as it holds huge potential for regenerative medicine, aiding in rare disease treatment, genetic screening, early detection, and scientific research. We’re proud to partner with DoH on this initiative, and we look forward to collaborating with them and other healthcare providers to drive progress in health and reinforce Abu Dhabi’s position as a global life science hub.”

The cord blood bank locally collects and preserves umbilical cord cells, offering donors the choice of preserving a newborn’s stem cells at birth, for potentially lifesaving treatments at no risk to them or their baby.

xpectant mothers can preserve their baby’s cord blood by opting for a safe, secure, painless, and non-intrusive process that can save lives and help build a healthier nation. They will have the opportunity to preserve the stem cells as part of public or private banking.

Source: Emirates News Agency

M42 unveils its next-gen Clinical LLM at inaugural ADGHW

ABU DHABI: M42, a global tech-enabled health powerhouse, has launched the next generation of its open-access generative AI Clinical Large Language Model (LLM), Med42, during Abu Dhabi Global Healthcare Week (ADGHW). Building upon the success of the initial launch, Med42 represents the next evolution in AI-driven health innovation, poised to advance healthcare AI and transform patient care, while helping reduce administrative burden for clinicians.

M42 unveiled Med42 in October 2023, setting a new standard for accuracy, efficiency, and accessibility in healthcare AI. With a score of 72 percent on the United States Medical Licensing Examination (USMLE) Sample Exam questions, the initial release outperformed OpenAI’s GPT3.5 and Google’s MedPaLM models. The model counts over 8,200 downloads to date from independent developers who have tested and validated the model’s performance. It continues to attract attention and acclaim worldwide.

This second iteration is a fully optimised 70-billion parameter finetuned mo
del based on Llama-3, Meta’s latest version of open-access LLMs. The new model’s performance is on par with proprietary (closed) models such as OpenAI’s GPT-4 and Google’s Med-Gemini, with a zero-shot accuracy score of 85.1 percent and a maximum accuracy score of 87.3 percent using specialised prompting on the USMLE. This highlights Med42’s efficiency and accessibility compared to larger, closed models and solidifies its position as a frontrunner in open-access clinical LLM technology.

Ashish Koshy, Group Chief Operating Officer of M42, said, ‘We are excited to release the second version of Med42, which represents a significant step forward in our mission to responsibly harness the power of AI for the benefit of patients and healthcare professionals. This release brings us closer to our vision of a composable multimodal AI platform that integrates expert models across health data modalities, including text, genomics, health records, and imaging. By enabling these models to collaborate and generate insights f
rom diverse data sources, we aim to tackle complex healthcare challenges that require a multimodal approach. Our sustained efforts in developing the Med42 platform underscore our commitment to making this vision a reality.”

Ashish further emphasised the importance of considering both leading and lagging indicators when assessing Med42’s performance, saying, ‘Benchmarks like the USMLE serve as valuable leading indicators of a model’s capabilities. However, the true measure of success lies in its real-world performance across specific applications. To that end, our interdisciplinary teams of AI experts and physician-scientists are actively conducting research studies to comprehensively evaluate and refine Med42’s performance in clinical settings.’

Med42 showcases the potential of automation in healthcare by streamlining documentation processes, alleviating administrative burdens, and supporting healthcare professionals. The AI model facilitates the retrieval of relevant insights, searches through patient hist
ories, and summarises records. Moreover, Med42 is being evaluated for its ability to craft tailored treatment strategies by analysing patients’ medical histories and determining optimal courses of action. The model also shows promise in serving as a clinical decision support tool for physicians, assisting pharmacists with accurate dosage decisions, and helping researchers efficiently review treatment literature.

Med42 is accessible through the HuggingFace platform, enabling extensive testing, contribution, review, and assessment by the global scientific and developer community. By making Med42 widely available, M42 aims to catalyze global innovation in AI, empowering experts worldwide to refine and expand the model’s applications across diverse medical domains, ultimately driving advancements in patient care and medical research.

Source: Emirates News Agency

MoHAP sets May 20 as launch date of ‘National Survey for Health and Nutrition’

DUBAI: The Ministry of Health and Prevention (MoHAP) has officially announced 20th May as the launch date of the National Survey for Health and Nutrition 2024 campaign, in collaboration with the Federal Competitiveness and Statistics Centre, health authorities, and local statistical centres.

The announcement follows the completion of all technical preparatory stages related to the national survey. The preparations included developing questionnaires approved by the World Health Organisation, available in four languages: Arabic, English, Hindi, and Urdu.

Additionally, doctors, researchers, field supervisors, auditors, and nurses underwent rigorous qualification and training processes to ensure the survey’s effectiveness.

The national survey campaigns are designed to update the population health database, measure health performance indicators, and provide valuable insights for policymakers and health experts.

By identifying needs and priorities, the survey seeks to facilitate proactive measures to address ex
isting health and nutritional challenges and ultimately enhance the quality of life for all residents. More details will be announced as the campaigns are launched.

The National Survey’s scope covers various segments of society, including adults aged eighteen and above, women of reproductive age, and pregnant women. The survey will target 20,000 families of citizens and residents, along with 2,000 workers across all the Emirates.

Source: Emirates News Agency

Khaled bin Mohamed bin Zayed inaugurates 1st Abu Dhabi Global Healthcare Week

ABU DHABI: H.H. Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council, has inaugurated the first edition of Abu Dhabi Global Healthcare Week (ADGHW), organised by the Department of Health – Abu Dhabi under the theme ‘Accelerating the Future of Global Healthcare’, and taking place at Abu Dhabi National Exhibition Centre (ADNEC) until 15th May.

During a tour of the exhibition, H.H. Sheikh Khaled was briefed on the latest innovations in healthcare technologies and developments in medical sciences being showcased by healthcare institutions and companies. The event is expected to attract 5,000 participants, including 1,000 delegates from participating countries, 100 exhibitors, and more than 250 expert speakers from around the world, who have gathered to exchange insights and discuss the latest scientific trends and technological initiatives in healthcare, including disease diagnostic systems, pharmaceutical manufacturing projects, and the development
of genomics and hereditary disease research, among other areas.

H.H. Sheikh Khaled highlighted that the UAE’s efforts in the healthcare sector, including launching several initiatives, innovative projects and programmes, reflect the leadership’s vision to provide advanced healthcare by accelerating research in medical and therapeutic fields, and by investing in strengthening healthcare infrastructure, including hospitals, healthcare facilities and specialised laboratories, to help further enhance the community’s health and quality of life.

He emphasised that organising this global event reflects Abu Dhabi’s commitment to supporting and encouraging investment in research and development in healthcare and life sciences by reinforcing cooperation and strategic partnerships between the public and private sectors to accelerate the transition to a preventive healthcare ecosystem that uses the most advanced innovations, while further strengthening Abu Dhabi’s position as a leading global healthcare hub that attrac
ts innovation and global talent.

Abu Dhabi Global Healthcare Week serves as a platform for dialogue and knowledge exchange about future healthcare needs and the transition to a proactive and preventive healthcare approach. The event aims to enhance collaborative action to develop results-oriented healthcare ecosystems that rely on sustainable and innovative infrastructure, designed to adapt to changing needs.

During its first day, the event is hosting the Healthcare Leaders Forum, which will welcome around 200 VIPs including ministers and public officials, CEOs, international investors, heads of multilateral organisations, and leading health and medicine experts, to discuss ways of taking action to address current challenges in global healthcare. The results and recommendations of the forum will serve as a foundation for developing future strategic healthcare plans.

The three-day Future Health Summit will host a wide variety of panel sessions and live discussions around themes central to healthcare, includ
ing the use of AI in medical research, human longevity research, genomics, biotechnology, and pharmaceuticals, among other themes.

Sheikh Khaled was accompanied by H.H. Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Deputy Chairman of the Presidential Court for Development and Fallen Heroes’ Affairs; Abdullah bin Sultan bin Awad Al Nuaimi, Minister of Justice; Dr. Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade; Dr. Mugheer Khamis Al Khaili, Chairman of the Department of Community Development; Sara Awadh Musallam, Chairwoman of Abu Dhabi Department of Education and Knowledge; Ahmed Jasim Al Zaabi, Chairman of the Abu Dhabi Department of Economic Development; Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi; Ahmed Tamim Al Kuttab, Chairman of the Department of Government Enablement; and Saif Saeed Ghobash, Secretary-General of the Abu Dhabi Executive Council.

Source: Emirates News Agency

M42 unveils Advisory Board of world-renowned health, technology experts

ABU DHABI: M42, a first-of-its-kind tech-enabled global health powerhouse, has unveiled a new Advisory Board, to impactfully disrupt and transform the global health sector through personalized, preventive and precision tech.

Comprising some of the world’s leading health and technology experts in the areas of personal remote care, pharmaceuticals, tech and longevity, the Advisory Board will drive M42’s vision to revolutionize the sustainable future of health by collaborating with international industry leaders. It will be key in guiding, advising and encouraging connections to drive industry growth. This reflects M42’s commitment to a holistic ‘health’ approach, by bringing together traditional health-tech and healthcare provisions. With a focus on preventive health solutions, M42’s innovation positions it as a leading force in the global health sector.

Hasan Jasem Al Nowais, Managing Director and Group Chief Executive Officer of M42, said, ‘As we embark on this journey to impactfully disrupt the traditional
healthcare industry, helping to put health back into our own hands, collaboration is key. I am proud to facilitate the M42 Advisory Board, collaborating with valued members who represent the pinnacle of expertise in both health and technology. The new M42 Advisory Board highlights our dedication to co-designing the future of health as we prioritize people, not just patients; health, not just healthcare; and prevention, not just treatment. We aim to encourage collaboration, drive innovation and excellence in the health-tech industry for the benefit of people across the world.’

In addition, the M42 Advisory Board will provide strategic direction for the future of health and invaluable insights into emerging trends and technologies. It will integrate environmental responsibility with health excellence and showcase a path for the industry to follow. Embracing a long-term vision, the M42 Advisory Board is committed to enhancing patient experiences worldwide and harnessing cutting-edge technologies to proactively
address and prevent health issues. It seeks to build strategic partnerships that provide complementary strengths and resources to drive innovation, expand market reach and create shared value for all stakeholders.

The members of the M42 Advisory Board each bring a wealth of experience and expertise from diverse fields. The group comprises:

-Dr. David Rhew, Global Chief Medical Officer at Microsoft.

-Professor Sir Chris Evans, Chief Executive Officer of Ellipses Pharma.

-David Sinclair, A.O., Ph.D., Professor of Genetics at Harvard Medical School.

-Dr. James Mault, Chief Executive Officer of BioIntelliSense.

Source: Emirates News Agency

Dubai Health welcomes a new cohort of Emirati nurses

DUBAI: Dubai Health, the first integrated academic health system in the emirate, has announced the addition of a new cohort of Emirati nurses to its team. This expansion strengthens healthcare delivery across the system and reflects Dubai Health’s commitment to nurturing and promoting local talent within the healthcare sector.

The new cohort, all graduates holding a Bachelor of Science in Nursing from the College of Health Sciences at the University of Sharjah, has been strategically placed across four locations within Dubai Health: Al Jalila Children’s Hospital, Rashid Hospital, Hatta Hospital, and Latifa Hospital.

Commenting on the announcement, Dr. Amer Sharif, Chief Executive Officer of Dubai Health, stated: ‘We are proud to continue to place local talent at the heart of the frontline workforce at Dubai Health. The latest cohort of Emirati nurses brings a wealth of knowledge and a local perspective to help our integrated academic health system elevate the standard of care and advance health for humanity
. We look forward to their contribution to serving Dubai and its communities.’

Khalifa Baqer, Chief Operating Officer at Dubai Health said: ‘The arrival of these talented Emirati nurses marks another significant milestone for Dubai Health. Their dedication and passion for healthcare delivery will undoubtedly enhance our services and patient care. We are proud to offer a supportive environment for Emirati talent and are fully committed to supporting these nurses as they contribute to our vision to advance health for humanity.’

Nursing at Dubai Health thrives with 4,300 dedicated nurses committed to advancing health. Through mentorship and development programmes, Dubai Health nurtures nursing leadership, empowering nurses to drive change in healthcare. The Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), which leads the Learning and Discovery missions, offers specialised master’s programmes tailored to local healthcare demands. The Master of Science in Cardiovascular Nursing and the Mast
er of Science in Pediatric Nursing equip nurses with skills for optimal patient care, shaping the future of nursing and elevating healthcare quality.

Source: Emirates News Agency

Critical Care Conference unveils resuscitation device with 20-meter range

DUBAI: The 20th Emirates Critical Care Conference, held in Dubai, showcased cutting-edge advancements in medicine. These include a remotely controlled cardiac resuscitation device with a 20-meter range. This innovation aims to minimise the risk of exposure to infectious diseases for medical personnel during resuscitation procedures. There is also a new dual anti-inflammatory drug designed to treat severe conditions like sepsis.

Assoc. Prof. Dr. Hussain Nasser Al Rahma, Founding Chairperson of the conference (ECCC-Dubai), Founding president of Emirates Intensive Care Society (EICS), President International Pan-Arab Critical Care Medicine Society (IPACCMS), said that the cardiopulmonary resuscitation device highlightes the latest advancement in cardiopulmonary resuscitation (CPR) technology. This new device, he said, combines CPR with remote cardiac catheterisation.

Dr. Hussein Al Rahma noted that 90% of hospital care departments nationwide are utilising modern technologies like artificial intelligence. This
has led to a significant improvement, with critical care patients experiencing recovery rates exceeding 90%.

These technologies, he added, have demonstrably reduced patient stays in critical care units and accelerated post-operative recovery.

‘Smart devices can now alert nurses or doctors when a patient’s vitals reach a stable state, allowing for the safe removal of oxygen support.’

Source: Emirates News Agency

Abu Dhabi Global Healthcare Week kicks off next Monday

ABU DHABI: Under the patronage of H.H. Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council, the inaugural edition of Abu Dhabi Global Healthcare Week (ADGHW) will be launched on Monday in the UAE capital under the theme ‘accelerating the future of global healthcare.’

Taking place between 13th to 15th May 2024, at the Abu Dhabi National Exhibition Centre (ADNEC), the global event is set to convene a distinguished assembly of healthcare leaders, researchers, policymakers, specialists, investors, and entrepreneurs across the global healthcare and life sciences ecosystem.

Hosted by the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, the always-on platform will witness a true gathering of pioneering minds and a powerful network of 5,000 attendees, 1,000 delegates, 200 speakers, and 100 exhibitors.

Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi (DoH), said, ‘Focused on dri
ving collaboration on priority topics, ADGHW aims to explore the shift from healthcare to health providing experts with a platform to exchange knowledge and experiences on crucial topics such as, ageing populations, non-communicable diseases, mental health and other common challenges as well as driving a bold conversation on proactive healthcare delivery. Centralised around driving impact, we aim through ADGHW to co-design tangible outcomes and transformative initiatives with global players to foster responsible innovation and pave the way for a healthier tomorrow for all.’

Dr.Al Ghaithi added, ‘Abu Dhabi has a track record of excellence and fast-growing, future-forward, data-enabled healthcare services. A platform such ADGHW spearheads a global effort to accelerate innovation and the development of novel approaches while making proactive health based on prediction, prevention and early intervention a global priority.

Hasan Jasem Al Nowais, Managing Director and Group Chief Executive Officer of M42, said, ‘
At M42 we are revolutionising global health. By leveraging cutting-edge technologies such as genomics and AI, we’re delivering personalised, precise, and preventive health solutions that are reshaping health and empowering individuals to manage their health and well-being.

At M42, we prioritise people, not just patients; health, not just healthcare; and prevention, not just treatment. We’re honoured to serve as the Foundation Partner for the inaugural Abu Dhabi Global Healthcare Week, supporting the Department of Health – Abu Dhabi in advancing global health innovation and driving adoption for a healthier world.’

Shaista Asif, Group Chief Executive Officer at PureHealth, said, ‘Under the government’s vision, Abu Dhabi has set new global benchmarks for healthcare excellence, built upon a robust ecosystem comprising some of the world’s most advanced facilities, technologies and companies.

The Emirate is the ideal platform to convene global healthcare leaders to address its future, and PureHealth is proud to
be the National Healthcare and Longevity Champion for Abu Dhabi Global Healthcare Week.

Under our participation, we will champion the transition from traditional healthcare models to a proactive, holistic system that promotes preventative care to enable longer, healthier and happier lives. We will engage with public and private sector leaders as we strive to elevate global health standards in line with Abu Dhabi’s efforts to foster lasting, positive change beyond its borders.’

During the first day of ADGHW, the programme will witness the Health Leaders Forum which will welcome around 200 VIPs including ministers and public officials, CEOs, international investors, innovators, heads of multilateral organisations, leading experts across science, health, and medicine to focus on how to tackle the changes and challenges of global health.

Furthermore, throughout the three-day event, the Future Health Summit will host keynote speeches, panel sessions, and discussions about themes central to the healthcare indust
ry, focusing on creating impact on an individual, community and global level. Themes range from Artificial Intelligence (AI) to microbiomes, regenerative medicine, longevity, and covering genomics to a fast-growing centre for preventative and precision medicine.

Source: Emirates News Agency